Table 3. The inhibitory effect of association the essential oil of P. salutare with fluconazole on Candida (µg/mL).
| Tested Products | Strains | |||||
|---|---|---|---|---|---|---|
| CA INCQS 40006 | CT INCQS 40042 | CK INCQS 40095 | ||||
| CFM µg/mL | IC50 µg/mL | CFM µg/mL | IC50 µg/mL | CFM µg/mL | IC50 µg/mL | |
| Fluconazole (FCZ) | 8,192 | 16.8 | ≥16,384 | 9.3 | ≥16,384 | 271 |
| OEFPs 1+FCZ | 1,024 | 2.7 | ≥16,384 | 2.6 | 8,192 | 44.4 |
| OEFPs 2+FCZ | 8,192 | 8.0 | ≥16,384 | 5.3 | 1,024 | 32.4 |
| OEFPs 3+FCZ | 4,096 | 6.3 | ≥16,384 | 3.7 | 8,192 | 45.2 |
Notes.
- OEFPs
- essential oil of Psidium salutare leaves, 1, 2 and 3 collections
- CA
- Candida albicans
- CT
- Candida tropicalis
- CK
- Candida krusei
- INCQS
- National Institute of Health Quality Control
- IC50 (µg/mL)
- the inhibitor concentration that decreases 50% of the growth